Clinical Trial

A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis( KOA)

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This clinical study is to investigate the safety and efficacy of NCR100 injection in subjects with knee osteoarthritis (KOA). It contains two parts dose-escalating, and blind random study in adult KOA subjects.
Trial Details
NCT Number NCT06741098
Lead Sponsor Nuwacell Biotechnologies Co., Ltd.
Collaborators: Shanghai 6th People's Hospital
Conditions Knee Osteoarthritis
Enrollment 162 participants
Start Date 2025-02-20
Primary Completion 2026-11-30 (estimated)
Study Completion 2028-11-15 (estimated)
Updated on ClinicalTrials.gov 2024-12-18